• Title/Summary/Keyword: 자궁 경부암

Search Result 212, Processing Time 0.022 seconds

흡연의 폐해

  • Seo, Hong-Gwan
    • 건강소식
    • /
    • v.30 no.5 s.330
    • /
    • pp.16-17
    • /
    • 2006
  • 모든 암 사망률의 30%가 흡연으로 밝혀졌다. 담배 연기가 직접 접촉하는 부위에 생기는 암인 구강암, 혀암, 식도암, 기관지암, 폐암은 흡연이 원인의 90%를 차지한다. 담배 연기가 직접 접촉하지 않는 부위에 생기는 암인 자궁경부암, 췌장암, 방광암, 신장암, 위암, 혈액암의 위험은 흡연으로 인하여 1.5~3.0배 정도 증가하게 된다.

  • PDF

A potential anticacner therapeutic strategy using light-emitting diode (자궁경부암세포 치료를 위한 발광다이오드의 응용)

  • Park, Chul Woo;Park, Kitae;Choi, Hojong;Choe, Se-woon
    • Proceedings of the Korean Institute of Information and Commucation Sciences Conference
    • /
    • 2017.05a
    • /
    • pp.712-713
    • /
    • 2017
  • Clinically applicable light emitting diode (LED) has been widely investigated because of relatively low heat generation, low cytotoxicity, and non-invasiveness compared to other therapeutic methods. Therefore, we investigated the therapeutic effects of several wavelengths of light emitting diode against human cervical cancer cells and analyzed the individual inhibitory effect for the cancer cell proliferation. In the experiment, prepared HeLa cells were exposed by red, green and blue light-emitting diode for 10 minutes each. Relatively short-wavelength light-emitting diode (blue) showed stronger therapeutic effects than relatively long-wavelength light-emitting diodes.

  • PDF

건강한 생활습관실천으로 암을 예방합시다

  • KOREA ASSOCIATION OF HEALTH PROMOTION
    • 건강소식
    • /
    • v.26 no.2 s.279
    • /
    • pp.6-13
    • /
    • 2002
  • 세계에서 매년 약 1,000만명의 새로운 암환자가 발생하고 있으며, 650만명이 암으로 사망하고 있다. 우리나라에서도 매년 약 85,000명의 새로운 암환자가 등록되고 있으며, 55,000명이 암으로 사망하고 있다. 이는 우리나라 전체 사망자의 20%를 차지하는 수치로서 사망원인으로는 단연 1위에 해당한다. 이처럼 암 발생과 암으로 인한 사망이 급격하게 증가함에 따라 암을 일으키는 원인인자를 밝히고 이러한 원인을 제거하여 암을 예방하려는 노력들이 활발하게 이루어지고 있다. 실제로 몇몇 암의 경우에는 그 발생 원인들이 일부 밝혀지고 있는데, 대표적으로 금연을 통하여 폐암의 발생을 예방하고 간염백신 접종을 통해 간암을 예방하는 경우 등이다. 한편, 세계보건기구에서는 의학적인 관점에서 암 발생인구 가운데 1/3은 예방가능하고, 1/3은 조기진단만 되면 완치가 가능하며, 나머지 1/3의 환자도 적절한 치료를 한다면 완치가 가능한 것으로 보고하고 있다. 특히 우리나라에서 가장 흔한 위암, 유방암, 자궁경부암, 대장암 등은 조기에 발견할 경우 거의 완치가 가능하기 때문에, 이러한 암들에 대해서 정기적으로 검진을 실시할 겨우 암으로 인한 사망을 상당수 줄일 수 있을 것으로 기대된다. 이에 정부는 2002년부터 저소득층을 대상으로 위암, 유방암, 자궁경부암에 대해 조기검진을 무료로 실시하고 있으며, 암 예방 교육 및 홍보를 통하여 국민들에게 암에 대한 정확한 지식과 조기검진의 중요성을 전달하고, 나아가 생활양식의 변화를 유도하여 암을 예방하도록 하는 마스터플랜을 추진하고 있다.

  • PDF

Gastric Metastasis from Gastric-Type Mucinous Adenocarcinoma of Uterine Cervix: A Case Report (자궁경부 위형 점액샘암종의 위 전이: 증례 보고)

  • Min Hye Kim;Kyeong Ah Kim;Yi Kyeong Chun;Jeong Woo Kim;Jongmee Lee;Chang Hee Lee
    • Journal of the Korean Society of Radiology
    • /
    • v.85 no.2
    • /
    • pp.445-450
    • /
    • 2024
  • Gastric metastasis (GM) from cervical cancer is extremely rare, and only a few cases have been reported in the English literature. Gastric-type mucinous adenocarcinomas (GAS) of the uterine cervix are rare. GAS is an aggressive cancer commonly found in advanced stages; however, GM has not been reported. This study presents a rare case of GM from GAS of the uterine cervix in a 61-year-old female and describes the radiological findings of both the GM and cervical mucinous adenocarcinoma. GM appeared as a poor enhancing submucosal mass. The cervical mucinous adenocarcinoma appeared as an infiltrating mass with poor contrast enhancement. It exhibited mildly high and low signal intensities on the diffusion-weighted image and apparent diffusion coefficient map, respectively. This case is extremely rare and challenging to diagnose; however, if cervical cancer is an human papillomavirus-independent GAS type and a submucosal lesion is found in the stomach, the possibility of metastasis with a pattern similar to our case could be considered.

A Study of Dose Distribution in Postoperative Radiotherapy in Uterine Cervical Cancer (자궁 경부암의 수술후 방사선 치료에서 선량 분포에 관한 연구)

  • Shin, Sei-One;Kim, Sung-Kyu;Kim, Myung-Se
    • Journal of Yeungnam Medical Science
    • /
    • v.8 no.1
    • /
    • pp.166-177
    • /
    • 1991
  • Uterine cervical cancer is the most common malignancy in korean women. In spite of recent development of early diagnostic and therapeutic modalities, about 40% of treated patient will develop relapse. So more aggressive local treatment such as more extensive surgery and higher radiation dose and administration of systemic chemotherapy will promote the curability but treatment related complications can not be avoidable. We used 22 cases of early cervical cancer, treated with surgery and post-operative radiotherapy, clinical data of these patients were analized to determine relationship between clinical parameters and final outcome. Three out of 22 cases revealed relapse and one patient showed rectovaginal fistula and another patient showed small bowel obstruction and the other patient showed rectal obstruction. Two out of three recurrence were stage IIa and the other one case was stage Ib adenocarcinoma with lymphovascular involvement. Nineteen out of 22 cases were followed without remarkable side effect or treatment related complication or sequelae. We concluded that our treatment policy was safe and effective to eradicate high risk postoperative cervical cancer with acceptable side effects or complication.

  • PDF

Cervical cancer screening strategies based on stochastic process (확률모형을 이용한 자궁경부암 조기검진 전략)

  • Phee, Young-Gyu;Lee, Jeong-Hee;Jeong, Seong-Hwa
    • Journal of the Korean Data and Information Science Society
    • /
    • v.21 no.1
    • /
    • pp.129-138
    • /
    • 2010
  • The purpose of this study was to investigate the most cost-effectiveness screening strategies for cervical cancer in Korea. We calculated the age-specific cervical cancer incidence rate from Korea Central Cancer Registry (2003), and then estimated the schedule sensitivity, detection probability, and screening and confirmative costs of each screening strategy based on the stochastic process (Lee and Zelen, 1998). The efficiency of the screening strategy was evaluated by incremental cost-effectiveness analysis. The most effective strategy was every 3 years pap smear test between the age of 35 and 65 years in the cervical cancer screening. The findings of this study will be helpful to evaluate efficiency of cancer screening strategies, and to provide the theoretical background of development and assessment of early detection of cancer in Korea.

Cox Model Improvement Using Residual Blocks in Neural Networks: A Study on the Predictive Model of Cervical Cancer Mortality (신경망 내 잔여 블록을 활용한 콕스 모델 개선: 자궁경부암 사망률 예측모형 연구)

  • Nang Kyeong Lee;Joo Young Kim;Ji Soo Tak;Hyeong Rok Lee;Hyun Ji Jeon;Jee Myung Yang;Seung Won Lee
    • The Transactions of the Korea Information Processing Society
    • /
    • v.13 no.6
    • /
    • pp.260-268
    • /
    • 2024
  • Cervical cancer is the fourth most common cancer in women worldwide, and more than 604,000 new cases were reported in 2020 alone, resulting in approximately 341,831 deaths. The Cox regression model is a major model widely adopted in cancer research, but considering the existence of nonlinear associations, it faces limitations due to linear assumptions. To address this problem, this paper proposes ResSurvNet, a new model that improves the accuracy of cervical cancer mortality prediction using ResNet's residual learning framework. This model showed accuracy that outperforms the DNN, CPH, CoxLasso, Cox Gradient Boost, and RSF models compared in this study. As this model showed accuracy that outperformed the DNN, CPH, CoxLasso, Cox Gradient Boost, and RSF models compared in this study, this excellent predictive performance demonstrates great value in early diagnosis and treatment strategy establishment in the management of cervical cancer patients and represents significant progress in the field of survival analysis.

Adjuvant Postoperative Radiation Therapy for Carcinoma of the Uterine Cervix (자궁경부암의 수술 후 방사선치료)

  • Lee Kyung-Ja;Moon Hye Seong;Kim Seung Cheol;Kim Chong Il;Ahn Jung Ja
    • Radiation Oncology Journal
    • /
    • v.21 no.3
    • /
    • pp.199-206
    • /
    • 2003
  • Purpose: This study was undertaken to evaluate the efficacy of postoperative radiotherapy, and to investigate the prognostic factors for FIGO stages IB-IIB cervical cancer patients who were treated with simple hysterectomy, or who had high-risk factors following radical hysterectomy and pelvic lymph node dissection. Materials and Methods: Between March 1986 and December 1998, 58 patients, with FIGO stages IB-IIB cervical cancer were included in this study. The indications for postoperative radiation therapy were based on the pathological findings, including lymph node metastasis, positive surgical margin, parametrial extension, lymphovascular invasion, invasion of more than half the cervical stroma, uterine extension and the incidental finding of cervix cancer fellowing simple hysterectomy. All patients received external pelvic radiotherapy, and 5 patients, received an additional intracavitary radiation therapy. The radiation dose from the external beam to the whole pelvis was $40\~50$ Gy. Vagina cuff Irradiation was peformed, after completion of the external beam irradiation, at a low-dose rate of Cs-137, with the total dose of $4488\~4932$ chy (median: 4500 chy) at 5 mm depth from the vagina surface. The median follow-up period was 44 months ($15\~108$ months). Results: The 5-yr actuarial local control rate, distant free survival and disease-free survival rate were $98\%,\;95\%\;and\;94\%$, respectively. A univariate analysis of the clinical and pathological parameters revealed that the clinical stage (p=0.0145), status of vaginal resection margin (p=0.0002) and parametrial extension (p=0.0001) affected the disease-free survival. From a multivariate analysis, only a parametrial extension independently influenced the disease-free survival. Five patients ($9\%$) experienced Grade 2 late treatment-related complications, such as radiation proctitis (1 patient), cystitis (3 patients) and lymphedema of the leg (1 patient). No patient had grade 3 or 4 complications. Conclusion: Our results indicate that postoperative radiation therapy can achieve good local control and survival rates for patients with stages IB-IIB cervical cancer, treated with a simple hysterectomy, as well as for those treated with a radical hysterectomy, and with unfavorable pathological findings. The prognostic factor for disease-free survival was invasion of the parametrium. The prognosic factor identified in this study for treatment failure can be used as a selection criterion for the combined treatment of radiation and che motherapy.

Convergence research on cytological diagnosis of gynecological diseases and genital HPV : Based on data from the Obstetrics and Gynecology Department of a general hospital located in Suwon-si (수원시 소재 일개 종합병원 산부인과에서 자궁경부 질환 검사의 실태조사 : HPV와 세포학적 검사의 융합연구)

  • Joung, You Hyun;Lee, Jun Min;Kim, Jong-Wan;Kim, Jae Kyung
    • Journal of the Korea Convergence Society
    • /
    • v.13 no.1
    • /
    • pp.119-129
    • /
    • 2022
  • Cervical cytology has been widely used as a screening tool for cervical cancer. However, Human papillomavirus (HPV) detection and subtype testing are suggested to overcome the high false-negative rate associated with cytology. We aimed to investigate the clinical usefulness and infection rate in the HPV polymerase chain reaction (PCR) test performed in hospitals. HPV PCR data from 217 patients were analyzed. Analysis of variance revealed a significant difference in the infection rate among different age groups (P=0.015). The biopsy results showed that epithelial cell abnormalities and high HPV-positivity rate was observed in 1 (100%) subject aged <29 years, in 4 out of 5 (80%) patients in their 30s, and in 3 out of 4 (75%) patients aged ≥70 years. The prevalence of HPV infection was very high (46.1%). The highest prevalence (87.5%) was observed among patients in their <29, followed by those in their 30s (67.7%) and those in their 40s (31.9%).A high rate of epithelial cell abnormalities (≥ cervical intraepithelial neoplasia type 1, mild dysplasia) was observed in HPV-infected women aged<30 years. Therefore, extensive research and prevention activities are needed in this age group. HPV PCR testing is recommended to complement cervical cytology